Index of /pdf
- Parent Directory
- 1.pdf
- 2.pdf
- 3.pdf
- 4.pdf
- BC approval 21-10-13.pdf
- Brossart-Blood1999.pdf
- Brossart-Blood2000.pdf
- CALALISIT ORPHAN.pdf
- CSO grant 2012- En.pdf
- Carmon Int.J.Can.pdf
- Challenges in the Development of Effective Peptide Vaccines for Cancer2002.pdf
- Collb Harvard.pdf
- D6 and Glycopeptide 2006.pdf
- Data mining of cancer vaccine trials 08.pdf
- Exp Ther Med Vol3 No6 Pg1092.pdf
- Globes 09-12.pdf
- Globes 10-12.pdf
- ImMucin vaccine 11.pdf
- Immunotherapy of established 2008.pdf
- Imucin_form_hebrew-new.pdf
- Israel Hayom 04-12.pdf
- Market Bridges-globes.pdf
- PR english 150611 v2.pdf
- Patient form BCancer.pdf
- Peptide TAA vaccine rev2010.pdf
- Scoring TAA for Cancer vaccines.pdf
- The Scientist _ Nice Shot.pdf
- The marker0712.pdf
- The telegraph 0412.pdf
- USC-TB-HEB.pdf
- VAXIL 3M$ 11.7.13.pdf
- VAXIL April 30-2014 HE.pdf
- VAXIL Breast Cancer Initiation Jan 2014 (3) (2) (2).pdf
- VAXIL EU orphan MM-final.pdf
- VAXIL Eng 010 BC study approval October 2013.pdf
- VAXIL FDA orphan MM.pdf
- VAXIL antibodies article Jan 2014 EN.pdf
- VAXIL-001 final results-final.pdf
- VAXIL-002 December 2012.pdf
- VAXIL-002 EN.pdf
- VAXIL-002 two patients reqruitment.pdf
- VXL PR 210212.pdf
- VXL-002 PR 06-13.pdf
- VaxHit-2-2011.pdf
- Vaxil 2M$ 23.6.14.pdf
- Vaxil Bio will move up to Main Board Listing 200113.pdf
- Vaxil BioTherapeutic Announced positive phase I-II results-EN.pdf
- Vaxil BioTherapeutics has completed the merger of its activities with Sheldonco -WEB.pdf
- Vaxil BioTherapeutics succesfuly recruited all patients needed for VAXIL-001 trial.pdf
- Vaxil Enabling technology-website.pdf
- Vaxil Orphan Drug EU - HEB.pdf
- Vaxil Presentation-website-2013 [Compatibility Mode].pdf
- Vaxil Profile Dec-2014.pdf
- WIS.pdf
- Yorkville-globes.pdf
- latercera.pdf
- vaxil PR TB USC collaboration 230113.pdf
- yediot 04-13.pdf
- âéåñ ùìåùä çåìéí ðåñôéí ìðéñåé 002.pdf
- äöìçä áðéñåé ÷ìéðéVAXIL-001-final-clean.pdf
- åå÷ñéì âìåáñ 23.6.14.jpg
- çéñåï èéôåìé ìçåìé ñøèï äú÷ååä äâãåìä.pdf
- èåôñ ìàéîéåöéï ðéñåé VXL-010.doc
- îòð÷ îãòï2012.pdf